SRL
VKTX icon

Scientech Research LLC’s Viking Therapeutics VKTX Stock Holding History

Scientech Research LLC’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$564K Buy
+14,456
New +$467K 0.46% 72
2025
Q2 		– Sell
-10,502
Closed -$254K – 868
2025
Q1 		$254K Buy
+10,502
New +$332K 0.07% 455
2024
Q3 		– Sell
-8,225
Closed -$436K – 859
2024
Q2 		$436K Buy
+8,225
New +$539K 0.09% 361

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Scientech Research LLC's VKTX Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 14,456 shares worth $564K. The stake represents 0.46% of the portfolio and ranks #72 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in VKTX as recently as Q1 2025.

Scientech Research LLC first reported a position in VKTX in Q2 2024 and has held it in 3 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Scientech Research LLC held 14,456 shares of Viking Therapeutics worth $564K as of Q2 2026.
  • Viking Therapeutics was a new Scientech Research LLC position in Q2 2026.
  • Viking Therapeutics made up 0.46% of Scientech Research LLC's portfolio in Q2 2026, its #72 holding.
  • Scientech Research LLC first reported a position in Viking Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.